Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of inhaled GW870086X in adults with persistent asthma
2010-022279-77Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing GW870086X once daily with Placebo once daily (2 arms). Primary endpoint: Change from baseline FEV1 at Day 28. Started Oct 2010; status: completed.
02
Drugs
GW870086
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-022279-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022279-77.